Table 2 Clinical characteristics of MINOCA patients and volunteers.

From: Reduced stress perfusion in myocardial infarction with nonobstructive coronary arteries

Clinical characteristics

MINOCA (n = 15)

Volunteers (n = 15)

p

Female sex, n (%)

9 (60%)

9 (60%)

1.00

Age (years)

59 ± 7

59 ± 7

0.85

Height (cm)

173 ± 10

173 ± 10

0.94

Weight (kg)

75 ± 15

71 ± 14

0.40

BSA(m2)

1.9 ± 0.2

1.8 ± 0.2

0.47

Creatinine (mmol/l)

71 ± 17

74 ± 12

0.40

EVF (%)

43 ± 5

43 ± 4

0.92

Hypertension, n (%)

8 (57%)

3 (20%)

0.06

Diabetes mellitus, n (%)

2 (14%)

1 (7%)

0.60

Hyperlipidemia, n (%)

5 (36%)

2 (13%)

0.39

Smoking currently, n (%)

4 (29%)

1 (7%)

0.17

Smoking previously, n (%)

9 (64%)

6 (40%)

0.14

Statins, n (%)

7 (50%)

1 (7%)

0.04

Beta blockers, n (%)

3 (21%)

2 (13%)

0.65

ACE-I/ARB, n (%)

6 (43%)

2 (13%)

0.11

Calcium channel blockers, n (%)

2 (14%)

1 (7%)

0.60

SAQ-7 summary score

100 [97–100]*

100 [100–100]

0.16†

  1. Clinical characteristics are presented as n (%) where p-values denotes the Fisher’s exact test or as median [interquartile range] or mean ± standard deviation where p-values denotes the independent t-test and † denotes the Mann Whitney U test. *Data missing for one patient. Significant values are in bold.
  2. MINOCA myocardial infarction with nonobstructive coronary arteries, BSA body surface area, EVF erythrocyte volume fraction, ACE-I angiotensin-converting-enzyme inhibitors, ARB angiotensin receptor blockers, SAQ-7 Seattle Angina Questionnaire-7.
Back to article page